First Light Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $51.1M | Buy |
3,383,553
+2,068,838
| +157% | +$36.1M | 3.1% | 13 |
|
|
2026
Q1 | $25.2M | Buy |
1,314,715
+225,222
| +21% | +$4.89M | 2.26% | 16 |
|
|
2025
Q4 | $23.9M | Buy |
+1,089,493
| New | +$19.7M | 1.83% | 24 |
|
|
2025
Q2 | – | Sell |
-245,257
| Closed | -$4.7M | – | 44 |
|
|
2025
Q1 | $4.7M | Sell |
245,257
-46,860
| -16% | -$1.37M | 0.54% | 32 |
|
|
2024
Q4 | $10.5M | Sell |
292,117
-733,190
| -72% | -$24.8M | 1.01% | 27 |
|
|
2024
Q3 | $43.5M | Buy |
1,025,307
+316,825
| +45% | +$13.4M | 3.62% | 11 |
|
|
2024
Q2 | $28.5M | Buy |
708,482
+233,405
| +49% | +$9.74M | 2.5% | 20 |
|
|
2024
Q1 | $16.8M | Buy |
475,077
+114,834
| +32% | +$3.08M | 1.29% | 31 |
|
|
2023
Q4 | $10.7M | Sell |
360,243
-1,080,723
| -75% | -$22.4M | 0.86% | 31 |
|
|
2023
Q3 | $29.9M | Buy |
1,440,966
+840,199
| +140% | +$23.1M | 2.84% | 14 |
|
|
2023
Q2 | $14.7M | Buy |
600,767
+11,582
| +2% | +$373K | 1.16% | 30 |
|
|
2023
Q1 | $23.9M | Buy |
589,185
+3,035
| +0.5% | +$126K | 2.15% | 18 |
|
|
2022
Q4 | $26.3M | Buy |
586,150
+100,530
| +21% | +$4.55M | 2.45% | 13 |
|
|
2022
Q3 | $23.2M | Buy |
485,620
+18,065
| +4% | +$990K | 2.35% | 17 |
|
|
2022
Q2 | $27.7M | Buy |
467,555
+32,250
| +7% | +$2.65M | 3.22% | 9 |
|
|
2022
Q1 | $50.6M | Buy |
435,305
+23,521
| +6% | +$2.75M | 4.47% | 7 |
|
|
2021
Q4 | $62M | Sell |
411,784
-67,402
| -14% | -$9.1M | 4.44% | 5 |
|
|
2021
Q3 | $57.2M | Sell |
479,186
-49,420
| -9% | -$5.45M | 3.77% | 6 |
|
|
2021
Q2 | $51.5M | Buy |
528,606
+3,477
| +0.7% | +$310K | 3.09% | 9 |
|
|
2021
Q1 | $46.3M | Buy |
525,129
+257,855
| +96% | +$24M | 3.07% | 12 |
|
|
2020
Q4 | $25.6M | Buy |
267,274
+10,069
| +4% | +$1.04M | 1.89% | 22 |
|
|
2020
Q3 | $29.2M | Sell |
257,205
-23,145
| -8% | -$2.43M | 2.99% | 11 |
|
|
2020
Q2 | $27.7M | Sell |
280,350
-5,841
| -2% | -$466K | 3.23% | 9 |
|
|
2020
Q1 | $18.4M | Buy |
286,191
+17,617
| +7% | +$1.23M | 3.14% | 10 |
|
|
2019
Q4 | $16M | Buy |
268,574
+132,246
| +97% | +$8.16M | 2.05% | 17 |
|
|
2019
Q3 | $8.04M | Sell |
136,328
-537
| -0.4% | -$34.3K | 1.22% | 26 |
|
|
2019
Q2 | $8.83M | Sell |
136,865
-131,089
| -49% | -$8.46M | 1.23% | 28 |
|
|
2019
Q1 | $17M | Buy |
267,954
+4,071
| +2% | +$214K | 2.21% | 18 |
|
|
2018
Q4 | $10M | Hold |
263,883
| – | – | 1.6% | 23 |
|
|
2018
Q3 | $11.3M | Sell |
263,883
-1,640,377
| -86% | -$57.3M | 1.82% | 20 |
|
|
2018
Q2 | $41.9M | Sell |
1,904,260
-2,829,978
| -60% | -$34.8M | 6.53% | 2 |
|
|
2018
Q1 | $23.5M | Buy |
+4,734,238
| New | +$15.3M | 5.16% | 7 |
|
Other funds holding TNDM
SC
GKIM
PIM
FGP
First Light Asset Management's TNDM Position: Q2 2026 in Review
First Light Asset Management increased its Tandem Diabetes Care (TNDM) stake by 157% in Q2 2026, buying an estimated $36.1M and bringing the position to 3,383,553 shares worth $51.1M. The position accounts for 3.1% of the portfolio, ranked #13.
First Light Asset Management first reported a position in TNDM in Q1 2018 and has held it in 32 quarters since. The position peaked at $62M in Q4 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- First Light Asset Management held 3,383,553 shares of Tandem Diabetes Care worth $51.1M as of Q2 2026.
- First Light Asset Management bought 2,068,838 Tandem Diabetes Care shares in Q2 2026, an estimated $36.1M.
- Tandem Diabetes Care made up 3.1% of First Light Asset Management's portfolio in Q2 2026, its #13 holding.
- First Light Asset Management first reported a position in Tandem Diabetes Care in Q1 2018 and has held it in 32 quarters since.
- First Light Asset Management's Tandem Diabetes Care position peaked at $62M in Q4 2021.
- 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.